PCOS is a common and complex disease affecting women of reproductive age. It is characterized by its complex pathological symptoms and mechanisms resulting in endocrine and metabolic dysfunction. PCOS is highly associated with various metabolic and endocrinal disorders. Metformin is mainly used for its glucose-lowering effects for treatment and prevention of type-2 diabetes mellitus (DM), gestational DM, and PCOS. Myo-inositol (MI) protects against MAFLD through reduction of hepatic accumulation of triglycerides.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
210
Met Group Received metformin hydrochloride 500 mg tab 3 times Daily
MI-group received MI/DCI combination in 40:1 ratio twice daily
MM Group Received both Met and MI Groups Treatment
Zagazig university
Zagazig, Ash Sharqia Governorate, Egypt
Improvement of mensural pattern
The Evaluation of the success rate of the applied regimens to gain mensural regular pattern in PCOS Women
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.